Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell Carcinoma
Clinical trial NCT04225364 · COMPLETED
Trial details
- NCT number
- NCT04225364
- Sponsor
- Guangzhou Institute of Respiratory Disease
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-17
- Primary completion
- 2021-01-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.